ClinicalTrials.gg
Status unknownNCT03375879Updated Apr 23, 2018

Bandage Contact Lens in Post Operative Ptosis Patients

An interventional study of Bandage contact lens in Ptosis and Blepharoptosis, sponsored by St. Joseph's Healthcare Hamilton. Status unknown at 1 site in Canada. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-23.

Sponsored by St. Joseph's Healthcare Hamilton · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Apr 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

This study is being conducted to determine whether the use of bandage contact lens after ptosis surgery provides any benefits for the patient or is unnecessary.

Read the detailed description

This study is being conducted to determine whether the use of bandage contact lens after ptosis surgery provides any benefits for the patient or is unnecessary. The investigators hope to show through questionnaires based on the patient's experience after their surgery to see if the bandage contact lens has provided any benefit for the patient. This is a randomized control trial in which patients undergoing bilateral ptosis surgery (Fasanella servat procedure) will have one of their eyes randomized to receive a bandage contact lens after surgery while the other eye will not receive anything.In this randomized control trial, patients requiring surgery with bilateral ptosis will have one eye randomized to receive a bandage contact lens whereas the other eye will not after their surgery. Follow up will occur in one week where the outcomes will be obtained through questionnaires.

02

Conditions studied

  • Ptosis
  • Blepharoptosis

Browse trials for

Keywords

  • Ptosis
  • Blepharoptosis
  • bandage contact lens
  • fasanella servat procedure
03

In context

Blepharoptosis

63 studies on the registry are indexed under Blepharoptosis; 16 are open to participants now.

This study's planned enrollment of 30 is below the median of 45 across 50 interventional studies indexed under Blepharoptosis.

Browse Blepharoptosis studies →

Lead sponsor

St. Joseph's Healthcare Hamilton is the lead sponsor of 143 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients who have bilateral ptosis (drooping eyelids) and will require surgery to correct this

Exclusion criteria

Exclusion Criteria:

  • patient having any other eye related pathologies
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Bandage contact lens

    Placing a bandage contact lens in one eye.

    Device: Bandage contact lens

  • No intervention
    Sham contact lens (immediate removal)

    Sham contact lens will be placed on other eye, placing it and immediately removing it so patient does not know which eye will have a bandage contact lens.

Interventions

  • DeviceBandage contact lens

    Bandage contact lens

06

What researchers measure

Primary outcomes

  1. Patient's pain/discomfort

    This will be obtained using the Eye Sensations Scale where the patient can select a box from None, Mild, Moderate, Severe, to Extreme.

    Time frame: One week post-operation.

Secondary outcomes

  1. Blurry vision

    This will be measured using one question from the Ocular Surface Disease Index (OSDI), with a scale from 0 (none of the time) to 4 (all of the time).

    Time frame: One week post-operation.

07

Study locations

1 of 1 sites recruiting
  • St. Joseph's Hospital Hamilton
    Hamilton, Ontario L8G 5E4, Canada
    • John Harvey, M.D. · Contact · johntharvey@gmail.com · 905-522 1155
    • John Harvey, M.D. · Principal investigator
    Recruiting
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 17, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — IPD will not be shared with others.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2018 (actual). Primary completion is estimated for Dec 2018, 9 months after the start.

Of 22 interventional studies with no phase under Blepharoptosis, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 62. This study's planned 9 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2017
First posted
Dec 18, 2017
StartActual
Feb 21, 2018
Primary completionEst.
Dec 1, 2018
CompletionEst.
Dec 1, 2018
Last update
Apr 23, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03375879
Collaborators
Robert Adam, Forough Farrokhyar, Sivisan Suntheralingam
Responsible party
John Harvey (Director of Oculoplastic, Reconstructive, Lacrimal and Orbital Service, St. Joseph's Healthcare Hamilton) — Principal investigator
First posted
Dec 18, 2017
Start date
Feb 21, 2018
Primary completion
Dec 1, 2018 (estimated)
Completion
Dec 1, 2018 (estimated)
Last update
Apr 23, 2018

Study contacts

John Harvey, M.D.
Contact
johntharvey@gmail.com
905-522 1155 ext. 38095

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion